This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1998 Jun;87(3):314.

doi: 10.1006/clin.1997.4497.

Retractions

No authors listed

PMID: 9657917
DOI: 10.1006/clin.1997.4497

Retractions

No authors listed. Clin Immunol Immunopathol. 1998 Jun.

. 1998 Jun;87(3):314.

doi: 10.1006/clin.1997.4497.

PMID: 9657917
DOI: 10.1006/clin.1997.4497

No abstract available

PubMed Disclaimer

Retraction of

Autolymphocyte therapy. II. Dependence of in vivo anti-tumor specificity and long-term immunity against murine melanoma and carcinoma on ex vivo activated donor memory T-cells.
Gold JE, Osband ME. Gold JE, et al. Clin Immunol Immunopathol. 1994 Jun;71(3):325-32. doi: 10.1006/clin.1994.1093. Clin Immunol Immunopathol. 1994. Retraction in: Clin Immunol Immunopathol. 1998 Jun;87(3):314. doi: 10.1006/clin.1997.4497. PMID: 7911078 Retracted.
Adoptively transferred ex vivo activated memory T cells with cyclophosphamide: effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE, Zachary DT, Osband ME. Gold JE, et al. Clin Immunol Immunopathol. 1994 Oct;73(1):115-22. doi: 10.1006/clin.1994.1177. Clin Immunol Immunopathol. 1994. Retraction in: Clin Immunol Immunopathol. 1998 Jun;87(3):314. doi: 10.1006/clin.1997.4497. PMID: 7923908 Retracted.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science